Dotti Patch, Extended Release
Product Images NDC 65162-993

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Dotti (NDC 65162-993). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Dotti Estradiol Transdermal System 1)

FDA Label Image

4a (Dotti Estradiol Transdermal System 10)

FDA Label Image

4b (Dotti Estradiol Transdermal System 11)

FDA Label Image

4c (Dotti Estradiol Transdermal System 12)

FDA Label Image

4d (Dotti Estradiol Transdermal System 13)

FDA Label Image

4e (Dotti Estradiol Transdermal System 14)

FDA Label Image

4f (Dotti Estradiol Transdermal System 15)

FDA Label Image

4g (Dotti Estradiol Transdermal System 16)

FDA Label Image

0.025 mg/day Pouch (Dotti Estradiol Transdermal System 17)

FDA Label Image

0.025 mg/day Carton (Dotti Estradiol Transdermal System 18)

FDA Label Image

0.0375 mg/day Pouch (Dotti Estradiol Transdermal System 19)

FDA Label Image

2 (Dotti Estradiol Transdermal System 2)

FDA Label Image

0.0375 mg/day Carton (Dotti Estradiol Transdermal System 20)

FDA Label Image

0.05 mg/day Pouch (Dotti Estradiol Transdermal System 21)

FDA Label Image

0.05 mg/day Carton (Dotti Estradiol Transdermal System 22)

FDA Label Image

0.075 mg/day Pouch (Dotti Estradiol Transdermal System 23)

FDA Label Image

0.075 mg/day Carton (Dotti Estradiol Transdermal System 24)

This is a transdermal patch for use only as directed, distributed by Aveal Pharmaceuticals. The package should be kept out of reach of children and is tamper-resistant. The directions for dosage and administration can be found in the package insert. The patch should be stored between 15°C to 30°C. The rest of the text is not-readable.*

FDA Label Image

0.1 mg/day Pouch (Dotti Estradiol Transdermal System 25)

FDA Label Image

0.1 mg/day Carton (Dotti Estradiol Transdermal System 26)

FDA Label Image

Figure 1 (Dotti Estradiol Transdermal System 3)

FDA Label Image

2 (Dotti Estradiol Transdermal System 4)

FDA Label Image

2 (Dotti Estradiol Transdermal System 5)

This text seems to be presenting the results of a study or experiment testing different dosages of Estradiol (a female hormone) and a placebo, measured in weeks 2, 7, and 104. The only readable piece of information is the dosage of the different treatments, with the highest being 0.0375 mg/day and the lowest being 0 mg/day. The rest of the text is not available due to errors.*

FDA Label Image

1 (Dotti Estradiol Transdermal System 6)

This appears to be a chart or table related to a study or trial involving different treatments (such as Estradol) and their impact over a period of time (weeks) on certain measurable outcomes. It also shows percentage change from baseline for some of the treatments. However, without further context, it is difficult to provide a more specific or useful description.*

FDA Label Image

1 (Dotti Estradiol Transdermal System 7)

The text provides instructions for the use of DOTTI, which is an estradiol transdermal system, USP. It specifies which days to change the patch, dividing them into Sun/Wed, Mon/Thu, Tue/Fri, and Wed/Sat, also listing the days as Thu/Sun, Fri/Mon, and Sat/Tue.*

FDA Label Image

2 (Dotti Estradiol Transdermal System 8)

FDA Label Image

3 (Dotti Estradiol Transdermal System 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.